| Literature DB >> 31775051 |
Martin Kiechle1, Bjoern von Einem1, Lennart Höfs2, Patrizia Voehringer3, Veselin Grozdanov1, Daniel Markx4, Rosanna Parlato5, Diana Wiesner1, Benjamin Mayer6, Olena Sakk7, Bernd Baumann7, Soeren Lukassen8, Birgit Liss9, Arif B Ekici8, Albert C Ludolph1, Paul Walther10, Boris Ferger3, Pamela J McLean11, Björn H Falkenburger2, Jochen H Weishaupt1, Karin M Danzer12.
Abstract
Intracellular accumulation of α-synuclein (α-syn) and formation of Lewy bodies are neuropathological characteristics of Parkinson's disease (PD) and related α-synucleinopathies. Oligomerization and spreading of α-syn from neuron to neuron have been suggested as key events contributing to the progression of PD. To directly visualize and characterize α-syn oligomerization and spreading in vivo, we generated two independent conditional transgenic mouse models based on α-syn protein complementation assays using neuron-specifically expressed split Gaussia luciferase or split Venus yellow fluorescent protein (YFP). These transgenic mice allow direct assessment of the quantity and subcellular distribution of α-syn oligomers in vivo. Using these mouse models, we demonstrate an age-dependent accumulation of a specific subtype of α-syn oligomers. We provide in vivo evidence that, although α-syn is found throughout neurons, α-syn oligomerization takes place at the presynapse. Furthermore, our mouse models provide strong evidence for a transsynaptic cell-to-cell transfer of de novo generated α-syn oligomers in vivo.Entities:
Keywords: Parkinson's disease; aging; alpha-synuclein; neurodegeneration; oligomerization; progressive phenotype; protein-fragment complementation; spreading; synaptic oligomers; transgenic mouse model
Mesh:
Substances:
Year: 2019 PMID: 31775051 DOI: 10.1016/j.celrep.2019.10.089
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423